Sophie-Athéna Chapron, Guilhem Bonazzi, Laura Di Lodovico, Julia de Ternay, Camille Landmann, et al.. Impact of psychedelics on craving in addiction: A systematic review. Journal of Psychopharmacology, 2025, ⟨10.1177/02698811241308613⟩. ⟨hal-04952959⟩
Perrine Roux, Aissatou Faye, Luis Sagaon‐teyssier, Cécile Donadille, Laélia Briand Madrid, et al.. Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study. Drug and Alcohol Review, 2024, 44 (1), pp.275-287. ⟨10.1111/dar.13955⟩. ⟨inserm-04929467⟩
Valentine Chirokoff, Sylvie Berthoz, Melina Fatseas, David Misdrahi, Maud Dupuy, et al.. Identifying the role of (dis)inhibition in the vicious cycle of substance use through ecological momentary assessment and resting-state fMRI. Translational Psychiatry, 2024, 14 (1), pp.260. ⟨10.1038/s41398-024-02949-1⟩. ⟨hal-04804003⟩
Emmanuelle Baillet, Cassandre Romao, Helene Garnier, Christophe Gauld, Chloé Vacher, et al.. Craving changes in first 14 days of addiction treatment: an outcome predictor of 5 years substance use status?. Translational Psychiatry, 2024, 14 (1), pp.497. ⟨10.1038/s41398-024-03193-3⟩. ⟨hal-04963569⟩
Sarah Perrin, Amandine Fillol, Sarah Moriceau, Lysiane Le Tirant, Axel Allache, et al.. Exploring and describing alcohol harm reduction interventions: a scoping review of literature from the past decade in the western world.. Harm Reduction Journal, 2024, 21 (1), pp.207. ⟨10.1186/s12954-024-01105-8⟩. ⟨hal-04909942⟩
P Roux, M Jauffret-Roustide, C Donadille, L Briand Madrid, C Denis, et al.. Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France: results from the COSINUS cohort. International Journal of Epidemiology, 2023, 52 (2), pp.562 - 576. ⟨10.1093/ije/dyac120⟩. ⟨inserm-04312540⟩
Christophe Gauld, Emmanuelle Baillet, Jean Arthur Micoulaud Franchi, Charlotte Kervran, Fuschia Serre, et al.. The centrality of craving in network analysis of five substance use disorders. Drug and Alcohol Dependence, 2023, 245, pp.109828. ⟨10.1016/j.drugalcdep.2023.109828⟩. ⟨hal-04028905⟩
Nolwenn Stevens, Judith Martin-Fernandez, Sarah Moriceau, Fuschia Serre, Marc Auriacombe, et al.. Realist evaluation of three programmes aimed at reducing harm and risks associated with alcohol consumption in the Nouvelle Aquitaine region of France: the ECIAE study protocol. BMJ Open, 2022, 12 (10), pp.e057928. ⟨10.1136/bmjopen-2021-057928⟩. ⟨hal-03887826⟩
Judith Martin-Fernandez, Nolwenn Stevens, Sarah Moriceau, Fuschia Serre, Helene Blanc, et al.. Realist evaluation of the impact, viability and transferability of an alcohol harm reduction support programme based on mental health recovery: the Vitae study protocol. BMJ Open, 2022, 12 (8), pp.e065361. ⟨10.1136/bmjopen-2022-065361⟩. ⟨hal-03833423⟩
L. Lambert, F. Serre, Bérangère Thirioux, Nemat Jaafari, M. Auriacombe. Preliminary Evidence That the Short Allele of 5-HTTLPR Moderates the Association of Psychiatric Symptom Severity on Suicide Attempt: The Example in Obsessive-Compulsive Disorder. Frontiers in Psychiatry, 2022, 13, pp.109391. ⟨10.1016/j.drugalcdep.2022.109391⟩. ⟨hal-03931553⟩
Marion Barrault-Couchouron, Marion Beracochea, Michel Dorval, Vincent Allafort, Valerie Barthelemy, et al.. Consommations de tabac et d’alcool chez des femmes traitées pour un cancer du sein dans un service de chirurgie oncologique : des comportements fréquents à considérer. Bulletin du Cancer, 2022, 109 (3), pp.307-317. ⟨10.1016/j.bulcan.2021.07.005⟩. ⟨hal-03970581⟩
Marie Jauffret-Roustide, Marc Auriacombe, Sébastien de Dinechin, Laélia Briand Madrid, Cécile Donadille, et al.. L'évaluation des salles de consommation à moindre risque en santé publique : la cohorte COSINUS (cohorte pour l'évaluation des facteurs structurels et individuels de l'usage de drogues). Politiques des drogues, 2022, 2, pp.34-42. ⟨hal-03621559⟩
Laura Lambert, Fuschia Serre, Berangere Thirioux, Nematollah Jaafari, Perrine Roux, et al.. Link Between Perception of Treatment Need and Craving Reports in Addiction. Frontiers in Psychiatry, 2022, 12, pp.790203. ⟨10.3389/fpsyt.2021.790203⟩. ⟨hal-03931558⟩
Rubaab Bahadoor, Jean-Marc Alexandre, Lucie Fournet, Thibaut Gelle, Fuschia Serre, et al.. Inventory and Analysis of Controlled Trials of Mobile Phone Applications Targeting Substance Use Disorders: A Systematic Review. Frontiers in Psychiatry, 2022, 12, pp.622394. ⟨10.3389/fpsyt.2021.622394⟩. ⟨hal-03798199⟩
Francois Arnaud Matthieu Jean, Julie Arsandaux, Ilaria Montagni, Ophélie Collet, Mélina Fatseas, et al.. Attention deficit hyperactivity disorder symptoms and cannabis use after one year among students of the i-Share cohort. European Psychiatry, 2022, 65 (1), pp.e25. ⟨10.1192/j.eurpsy.2022.14⟩. ⟨hal-03648957⟩
Déborah Loyal, Anne-Laure Sutter, Marc Auriacombe, Fuschia Serre, Nicole Rascle. The Pregnant Smoker Stigma Scale – Public Stigma (P3S-PS): development and validation in general French population. Women and Health, 2022, pp.1-11. ⟨10.1080/03630242.2022.2030449⟩. ⟨hal-03550723⟩
Pierre Philip, Lucile Dupuy, Patricia Sagaspe, Etienne de Sevin, Marc Auriacombe, et al.. Efficacy of a Smartphone-Based Virtual Companion to Treat Insomniac Complaints in the General Population: Sleep Diary Monitoring Versus an Internet Autonomous Intervention. Journal of Clinical Medicine, 2022, 11 (15), pp.4387. ⟨10.3390/jcm11154387⟩. ⟨hal-03819927⟩
Deborah Loyal, Anne-Laure Sutter-Dallay, Marc Auriacombe, Fuschia Serre, Nicolas Calcagni, et al.. Stigma Attached to Smoking Pregnant Women: A Qualitative Insight in the General French Population. Nicotine and Tobacco Research, 2021, ⟨10.1093/ntr/ntab190⟩. ⟨hal-03438997⟩
Maud Dupuy, Majd Abdallah, Joel Swendsen, Bernard N’kaoua, Sandra Chanraud, et al.. Real-time cognitive performance and positive symptom expression in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 2021, ⟨10.1007/s00406-021-01296-2⟩. ⟨hal-03437982⟩
Maud Dupuy, Majd Abdallah, Joel Swendsen, Bernard N’kaoua, Sandra Chanraud, et al.. Real-time cognitive performance and positive symptom expression in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, In press, ⟨10.1007/s00406-021-01296-2⟩⟩. ⟨hal-03437979⟩
Marc Auriacombe, Lucie Fournet, Lucile Dupuy, Jean Arthur Micoulaud Franchi, Etienne de Sevin, et al.. Effectiveness and Acceptance of a Smartphone-Based Virtual Agent Screening for Alcohol and Tobacco Problems and Associated Risk Factors During COVID-19 Pandemic in the General Population. Frontiers in Psychiatry, 2021, 12, ⟨10.3389/fpsyt.2021.693687⟩. ⟨hal-03798149⟩
C. Kervran, D. Shmulewitz, F. Serre, C. Denis, P. Roux, et al.. Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approach. Addictive Behaviors, 2021, 116, pp.106797. ⟨10.1016/j.addbeh.2020.106797⟩. ⟨hal-03471669⟩
Marie Grall-Bronnec, Morgane Guillou-Landréat, Julie Caillon, Caroline Dubertret, Lucia Romo, et al.. Five-year follow-up on a sample of gamblers: predictive factors of relapse. Journal of Behavioral Addictions, 2021, 10 (1), pp.42-54. ⟨10.1556/2006.2021.00009⟩. ⟨hal-03211052⟩
S. Digé, L.-A. Jakubiec, M. Auriacombe. Les soins sans consentements peuvent-ils s’appliquer en cas d’addiction dans le contexte français ? Une analyse critique des données. L'Encéphale, 2020, 46, pp.471 - 481. ⟨10.1016/j.encep.2020.04.012⟩. ⟨hal-03493666⟩
Shérazade Kinouani, Chloé Leflot, Paul Vanderkam, Marc Auriacombe, Emmanuel Langlois, et al.. Motivations for using electronic cigarettes in young adults: A systematic review. Substance Abuse, 2020, 41 (3), pp.315-332. ⟨10.1080/08897077.2019.1671937⟩. ⟨halshs-02401948⟩
Loriane Benchebra, Jean-Marc Alexandre, Jacques Dubernet, Mélina Fatséas, Marc Auriacombe. Addiction aux jeux (d’argent et vidéo) et état de santé des joueurs : une revue critique de la littérature. La Presse Médicale, 2019, 48, pp.1551 - 1568. ⟨10.1016/j.lpm.2019.10.014⟩. ⟨hal-03488832⟩
Hadrien Leouzon, Jean-Marc Alexandre, Mélina Fatséas, Marc Auriacombe. L’addiction aux jeux vidéo dans le DSM-5, controverses et réponses relatives à son diagnostic et sa définition. Annales Médico-Psychologiques, Revue Psychiatrique, 2019, 177, pp.610 - 623. ⟨10.1016/j.amp.2019.03.013⟩. ⟨hal-03488132⟩
Marc Auriacombe, Perrine Roux, Laélia Briand Madrid, Sébastien Kirchherr, Charlotte Kervran, et al.. Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol. BMJ Open, 2019, 9 (2), pp.e023683. ⟨10.1136/bmjopen-2018-023683⟩. ⟨hal-02479765⟩
Fuschia Serre, Melina Fatseas, Cecile Denis, Joel Swendsen, Marc Auriacombe. Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: Commonalities and specificities across substances. Addictive Behaviors, 2018, 83, pp.123-129. ⟨10.1016/j.addbeh.2018.01.041⟩. ⟨hal-02388242⟩
J. Dupouy, A. Vergnes, C. Laporte, Sherazade Kinouani, M. Auriacombe, et al.. Intensity of previous teaching but not diagnostic skills influences stigmatization of patients with substance use disorder by general practice residents. A vignette study among French final-year residents in general practice. European Journal of General Practice, 2018, 24 (1), pp.160-166. ⟨10.1080/13814788.2018.1470239⟩. ⟨hal-03164784⟩
M Fatseas, F Serre, J Swendsen, M. Auriacombe. Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study.. Drug and Alcohol Dependence, 2018. ⟨hal-02388279⟩
A Bouvard, M Dupuy, P Schweitzer, M Revranche, M Fatseas, et al.. Feasibility and validity of mobile cognitive testing in patients with substance use disorders and healthy controls.. American Journal on Addictions, 2018. ⟨hal-02388274⟩
B. Rolland, D. Bouhassira, N. Authier, M. Auriacombe, V. Martinez, et al.. Mésusage et dépendance aux opioïdes de prescription : prévention, repérage et prise en charge. La Revue de Médecine Interne, 2017, 38 (8), pp.539 - 546. ⟨10.1016/j.revmed.2016.12.024⟩. ⟨hal-01691052⟩
B. Rolland, D. Bouhassira, N. Authier, M. Auriacombe, V. Martinez, et al.. Mésusage et dépendance aux opioïdes de prescription : prévention, repérage et prise en charge. La Revue de Médecine Interne, 2017, 38 (8), pp.539 - 546. ⟨10.1016/j.revmed.2016.12.024⟩. ⟨hal-01662482⟩
Julie Dupouy, Aurore Palmaro, Mélina Fatséas, Marc Auriacombe, Joëlle Micallef, et al.. Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study. Annals of Family Medicine, 2017, 15 (4), pp.355-358. ⟨10.1370/afm.2098⟩. ⟨hal-03599002⟩
Daniel Werb, Richard Garfein, Thomas Kerr, Peter Davidson, Perrine Roux, et al.. A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study. Harm Reduction Journal, 2015, 13 (1), pp.25. ⟨10.1186/s12954-016-0114-1⟩. ⟨inserm-01366614⟩
Marion Malivert, Mélina Fatseas, Cécile Denis, Emmanuel Langlois, Marc Auriacombe. Effectiveness of therapeutic communities: a systematic review. European Addiction Research, 2012, 18 (1), pp.1-11. ⟨10.1159/000331007⟩. ⟨halshs-00646645⟩
Cécile Denis, Emmanuel Langlois, Mélina Fatseas, Marc Auriacombe. Un modèle français de Communauté Thérapeutique ? Les communautés thérapeutiques expérimentales : Consensus des professionnels. Psychotropes, 2011, Les communautés thérapeutiques, 17 (3-4), pp.81-97. ⟨10.3917/psyt.173.0085⟩. ⟨halshs-00681281⟩
Gaëlle Encrenaz, Virginie Rondeau, Antoine Messiah, Marc Auriacombe. Examining the influence of drop-outs in a follow-up of maintained opiate users.. Drug Alcohol Depend, 2005, 79 (3), pp.303-10. ⟨10.1016/j.drugalcdep.2005.01.021⟩. ⟨inserm-00138541⟩
J Swendsen, M Dupuy, M Abdallah, P Schweitzer, M Fatseas, et al.. Smartphone-Based Assessment of Executive Functions and the Real-Time Prediction of Symptoms in Schizophrenia and Substance Use Disorders. Annual Meeting of the American Psychiatric Association, May 2019, San Francisco, United States. ⟨hal-02388302⟩
J Swendsen, P Schweitzer, M Dupuy, D Misdrahi, F Serre, et al.. Mobile Cognitive Testing in Mental Health: A New Era for Ecological Momentary Assessment.. Annual Convention of the American Psychological Association, Jul 2018, San Francisco, United States. ⟨hal-02388298⟩
J. Pradeille, N. Chakroun, V. Beltran, A. Aguerretxe-Colina, M. Auriacombe, et al.. The Marquis reaction as a harm reduction element in party atmospheres: An assessment of the on-site testing of ecstasy tablets.. 70th Annual Meeting of the College on Problems of Drug Dependence College, Jun 2008, San Juan, Puerto Rico. ⟨hal-00336335⟩
J. Pradeille, N. Chakroun, V. Beltran, A. Aguerretxe-Colina, M. Auriacombe, et al.. The Marquis reaction as a harm reduction element in party atmospheres: An assessment of the on-site testing of ecstasy tablets.. 161th Annual Meeting of the American Psychiatric Association, May 2008, Whashington, DC, United States. ⟨hal-00336336⟩
R. Charlet de Sauvage, I. Lagroye, B. Billaudel, Christophe Daudet, M. Auriacombe, et al.. Effects of rTMS signals applied on the rat brain: potential genotoxicity and mechanism of an antidepressant effect. 28th Annual Meeting of the BEMS, Jun 2006, Cancun, Mexico. ⟨hal-00161910⟩
Gaëlle Encrenaz, Virginie Rondeau, Antoine Messiah, Marc Auriacombe. Une illustration de l'influence des sorties d'étude informatives sur les résultats d'une étude longitudinale d'usagers d'opiacés en traitement de substitution.. Congrès de l'Association des Epidémiologistes de Langue Française, Sep 2004, Bordeaux, France. ⟨hal-00999472⟩
Mélina Fatséas, P. Franques-Rénéric, Gaëlle Encrenaz, J. Swendsen, Jean Tignol, et al.. The role of the reinforcing effect of substances and motivation for psychoactive substance use and substance choice. Annual Scientific Meeting of the College on Problems of Drug Dependence, 2004, Puerto Rico. ⟨hal-01000109⟩
Marc Auriacombe, Emmanuel Langlois, Charlotte Kervan, Bérengère Gelot. Étude de santé publique : population bordelaise des injecteurs et intérêt de la création d’une SCMR à Bordeaux. [Rapport de recherche] Centre Hospitalier Charles Perrens; Université de Bordeaux; Agence régionale de santé Aquitaine. 2016, pp.32. ⟨halshs-02511950⟩
Cécile Denis, Mélina Fatseas, Emmanuel Langlois, Antoine Vérétout, Marc Auriacombe. Évaluation des communautés thérapeutiques en France. Quelle mise en oeuvre, quels résultats ? Etude prospective sur deux ans dans quatre communautés thérapeutiques. [Rapport de recherche] Observatoire français des drogues et toxicomanies (OFDT); Mission interministérielle de lutte contre la drogue et la toxicomanie (MILDT); Direction générale de la santé (DGS). 2011. ⟨halshs-00594027⟩
